Old Web
English
Sign In
Acemap
>
Paper
>
Impact of Novel Agents on Outcomes of Patients with Classical Hodgkin Lymphoma and Primary Treatment Failure
Impact of Novel Agents on Outcomes of Patients with Classical Hodgkin Lymphoma and Primary Treatment Failure
2019
Narendranath Epperla
Luciano J. Costa
John L. Vaughn
Walter Hanel
Saba Raya
Amanda F. Cashen
Rehan Sarmad
Talha Badar
Mehdi Hamadani
Yang Liu
Stefan K. Barta
Paolo Caimi
Tarsheen K. Sethi
Nishitha Reddy
Madelyn Burkart
Reem Karmali
Celeste M. Bello
Julio C. Chavez
Shalin Kothari
Francisco J. Hernandez-Ilizaliturri
Hatcher J. Ballard
Jakub Svoboda
Lukas Emery
Frederick Lansigan
Martha Glenn
Michael C Churnetski
Jonathon B. Cohen
Caryn E. Sorge
Ana C. Xavier
Keywords:
Immunology
Oncology
Internal medicine
Classical Hodgkin lymphoma
Medicine
novel agents
primary treatment
Brentuximab vedotin
Chlorambucil
Chemotherapy regimen
Hematopoietic stem cell transplantation
Salvage therapy
Lymphoma
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]